Exclusive report - According to sources, Galderma has agreed to acquire ZO Skin Health for approximately $1.5 billion.
路透社2026/10/13 23:21Abigail Summerville
Reuters New York, October 13 - According to two people familiar with the matter, Swiss skincare group Galderma (GALD.S) has agreed to acquire medical-grade skincare company ZO Skin Health for approximately $1.5 billion.
Sources stated the deal could be announced in the coming days.
ZO and Galderma, contacted outside regular business hours, did not immediately respond to requests for comment.
Last month, Reuters (link) reported that ZO’s parent company—investment firm Blackstone Group BX.N—was exploring a potential sale with investment banks Citigroup C.N and Raymond James RJF.N. Blackstone Group declined to comment on Tuesday.
This move by dermatology company Galderma, in which beauty giant L'Oréal (OREP.PA) holds a 20% stake, will expand its presence in the US market. In August, the company established its US and Latin America headquarters in Miami.
Founded in 1981, Galderma also owns the skincare brands Cetaphil and Alastin Skincare, acne gels Differin Epiduo, injectable neurotoxin Dysport, and dermal filler brand Restylane.
Many strategic buyers are prioritizing clinically proven skincare brands like ZO, which are sold through physician channels, since these brands not only offer significant efficacy compared to over-the-counter products, but also have more stable demand.
Dermatologist Zein Obagi founded ZO in 2007. ZO’s skincare products—including cleansers, serums, exfoliants, and toners—are distributed through doctors and skincare professionals.
Blackstone Group acquired ZO in 2020 through its Tactical Opportunities Fund.
(To make its reporting more accessible to non-English speakers, Reuters has automatically translated this article into several other languages. As automated translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the translated text and provides it solely for reader convenience. Reuters accepts no responsibility for any damage or loss arising from the use of the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Financial Report Soared 322% but Shares Fell Nearly 4%: Technical Death Cross Suppresses APLD (APLD.US)
App’s Q1 revenue reached $300 millions, surpassing expectations. However, due to weakness in tech stocks and a technical death cross, the stock price fell by 3.78%. Analysts maintain a buy rating and are closely watching whether the key support level at $19.5 can hold.
Getty bankruptcy privatization: AI impact collapses a 5 billion empire
Getty Images has filed for bankruptcy due to the impact of AI and a debt crisis, with its stock price plummeting by 99.95%. The family and Koch Equity have injected $533 millions for privatization, aiming to transition toward AI training authorization.
Storage stocks suffer growing pains from a narrative shift! Roundhill suggests a "barbell strategy": large-cap growth plus "halo stocks"
Drew Pettit, Chief Investment Strategist at Roundhill Investments, stated that the market does not favor stocks with a transitional narrative, and currently, storage stocks are in such an awkward position.
The largest single-week net purchase in fifteen years! Citadel analyst: Retail investors are buying AI stocks again
Retail investors are bottom-fishing AI stocks, with a net purchase of $9.1 billion in one week, marking a 15-year record! According to Citadel Securities data, funds are highly concentrated in semiconductors and AI infrastructure. However, this is not a broad-based buying frenzy, but rather a directional overweight, with buying skewed to the 90th percentile of the past year.
Crypto prices
More
